Judy Ashworth

Judy was appointed as part-time Chief Medical Officer of Novadip Biosciences in December of 2022, designated by Pinney Associates where she resides as Vice President, Rx Strategic Services & CMO. Before Novadip, Judy was a clinical lead at Grünenthal’s for their U.S. and EU marketing registration. She has over two decades of experience in drug development delivery, specializing in clinical development plans and trial design, regulatory strategy and target product profiles. Judy received her bachelor’s degree in Biology from the University of California Santa Barbara and her Medical Doctorate from the University of California Los Angeles, complemented by a residency in internal medicine at Santa Barbara Cottage Hospital.